RNA BRAINWAY
Live / Applied — Non-final action mailed (as of 23 Sept 2026)
What this means for you
Not registered yet, but its 19 May 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99831730
- Mark type
- Word mark
- Filed
- 19 May 2026
- Attorney of record
- Rachelle A. Dubow
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely antivirals; Pharmaceutical products for the treatment of viral and infectious diseases; Pharmaceutical products for the treatment of cancer; pharmaceutical preparations, namely, vaccines; Pharmaceutical products for treating respiratory diseases; Pharmaceutical preparations, namely, a drug delivery system comprising polymer nanoparticles for the release of a wide variety of therapeutic agents
- Class 042 — Scientific and technological services: Pharmaceutical research and development
Owner
- Xanadu Bio, Inc., Gladwyne, PA, US
Prosecution history
- 23 Sept 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 23 Sept 2026 — NON-FINAL ACTION E-MAILED
- 23 Sept 2026 — NON-FINAL ACTION WRITTEN
- 15 Sept 2026 — ASSIGNED TO EXAMINER
- 31 Jul 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 19 May 2026 — APPLICATION FILING RECEIPT MAILED
- 19 May 2026 — NEW APPLICATION ENTERED